Attitude, knowledge and factors associated with influenza and pneumococcal vaccine uptake in a large cohort of patients with secondary immune deficiency

Vaccine

Volumn 33, Issue 31, 2015, Pages 3703-3708

  Loubet, Paul ^a,b   Kernéis, Solen ^a,b,c   Groh, Matthieu ^b,c   Loulergue, Pierre ^a,c   Blanche, Philippe ^b   Verger, Pierre ^a,d,e   Launay, Odile ^a,b,c  

^a INSERM   (France)

^b Institut Cochin   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d AIX MARSEILLE UNIV   (France)

^e OBSERVATOIRE RÉGIONAL DE LA SANTÉ PROVENCE ALPES CÔTE D AZUR   (France)

Author keywords

Immunocompromised; Influenza; Knowledge, Attitudes; Pneumococcal; Vaccination

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; INFLUENZA VACCINE; METHOTREXATE; MYCOPHENOLATE MOFETIL; PNEUMOCOCCUS VACCINE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; AGED; ARTICLE; AWARENESS; BIOLOGICAL THERAPY; CONTROLLED STUDY; EDUCATIONAL STATUS; FEMALE; GRAFT RECIPIENT; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNE DEFICIENCY; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; INFLUENZA VACCINATION; KNOWLEDGE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PATIENT ATTITUDE; PNEUMOCOCCAL INFECTION; PREVALENCE; PRIORITY JOURNAL; SEASONAL INFLUENZA; SECONDARY IMMUNE DEFICIENCY; SELF EVALUATION; SELF REPORT; VACCINATION; YOUNG ADULT; ADOLESCENT; ATTITUDE TO HEALTH; COHORT ANALYSIS; FRANCE; IMMUNOCOMPROMIZED PATIENT; IMMUNOLOGY; INFLUENZA, HUMAN; PNEUMOCOCCAL INFECTIONS; QUESTIONNAIRE; UTILIZATION; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; FRANCE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SURVEYS AND QUESTIONNAIRES; VACCINATION; YOUNG ADULT;

EID: 84937634428     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.06.012     Document Type: Article

References (48)

1. Van Staa T.P., Leufkens H.G., Abenhaim L., Begaud B., Zhang B., Cooper C. Use of oral corticosteroids in the United Kingdom. QJM Mon J Assoc Physicians 2000, 93(2):105-111.
2. 2009 OPTN/SRTR annual report [Internet]. [cité 1 juin 2014]. Disponible sur: 〈http://www.srtr.org/annual_reports/archives/2009/2009_Annual_Report/default.htm〉.
3. Kunisaki K.M., Janoff E.N. Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infect Dis 2009, 9(8):493-504.
4. Duchini A., Hendry R.M., Redfield D.C., Pockros P.J. Influenza infection in patients before and after liver transplantation. Liver Transpl 2000, 6(5):531-542.
5. Vilchez R.A., Fung J., Kusne S. The pathogenesis and management of influenza virus infection in organ transplant recipients. Transpl Infect Dis Off J Transplant Soc 2002, 4(4):177-182.
6. Couch R.B., Englund J.A., Whimbey E. Respiratory viral infections in immunocompetent and immunocompromised persons. Am J Med 1997, 102(3A):2-9. (Discussion 25-6).
7. Elting L.S., Whimbey E., Lo W., Couch R., Andreeff M., Bodey G.P. Epidemiology of influenza A virus infection in patients with acute or chronic leukemia. Support Care Cancer Off J Multinatl Assoc Support Care Cancer 1995, 3(3):198-202.
8. Schepetiuk S., Papanaoum K., Qiao M. Spread of influenza A virus infection in hospitalised patients with cancer. Aust N Z J Med 1998, 28(4):475-476.
9. Kyaw M.H., Rose C.E., Fry A.M., Singleton J.A., Moore Z., Zell E.R., et al. The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults. J Infect Dis 2005, 192(3):377-386.
10. Hak E., Buskens E., van Essen G.A., de Bakker D.H., Grobbee D.E., Tacken M.A.J.B., et al. Clinical effectiveness of influenza vaccination in persons younger than 65 years with high-risk medical conditions: the PRISMA study. Arch Intern Med 2005, 165(3):274-280.
11. Rahier J.-F., Moutschen M., Van Gompel A., Van Ranst M., Louis E., Segaert S., et al. Vaccinations in patients with immune-mediated inflammatory diseases. Rheumatol Oxf Engl 2010, 49(10):1815-1827.
12. Amber I.J., Gilbert E.M., Schiffman G., Jacobson J.A. Increased risk of pneumococcal infections in cardiac transplant recipients. Transplantation 1990, 49(1):122-125.
13. Gabriel S.E., Michaud K. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther 2009, 11(3):229.
14. Schneeweiss S., Setoguchi S., Weinblatt M.E., Katz J.N., Avorn J., Sax P.E., et al. Anti-tumor necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis. Arthritis Rheum 2007, 56(6):1754-1764.
15. Doran M.F., Crowson C.S., Pond G.R., O'Fallon W.M., Gabriel S.E. Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum 2002, 46(9):2287-2293.
16. Lacaille D., Guh D.P., Abrahamowicz M., Anis A.H., Esdaile J.M. Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis. Arthritis Rheum 2008, 59(8):1074-1081.
17. Franklin J., Lunt M., Bunn D., Symmons D., Silman A. Risk and predictors of infection leading to hospitalisation in a large primary-care-derived cohort of patients with inflammatory polyarthritis. Ann Rheum Dis 2007, 66(3):308-312.
18. Bakland G., Gran J.T., Nossent J.C. Increased mortality in ankylosing spondylitis is related to disease activity. Ann Rheum Dis 2011, 70(11):1921-1925.
19. Flossmann O., Berden A., de Groot K., Hagen C., Harper L., Heijl C., et al. Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis 2011, 70(3):488-494.
20. Vaccinations des personnes immunodéprimées ou aspléniques. Recommandations [Internet]. [cité 16 févr 2014]. Disponible sur: 〈http://www.hcsp.fr/Explore.cgi/avisrapportsdomaine?clefr=322〉.
21. Centers for Disease Control and Prevention (CDC) Prevention and control of seasonal influenza with vaccines Recommendations of the Advisory Committee on Immunization Practices-United States, 2013-2014. MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep Cent Dis Control 2013, 62(RR-07):1-43.
22. Papadopoulou D., Sipsas N.V. Comparison of national clinical practice guidelines and recommendations on vaccination of adult patients with autoimmune rheumatic diseases. Rheumatol Int 2014, 34(2):151-163.
23. Rubin L.G., Levin M.J., Ljungman P., Davies E.G., Avery R., Tomblyn M., et al. IDSA Clinical Practice Guideline for vaccination of the immunocompromised host. Clin Infect Dis 2013, 58(Jan (3)):e44-e100.
24. Beck C.R., McKenzie B.C., Hashim A.B., Harris R.C., Nguyen-Van-Tam J.S. Influenza vaccination for immunocompromised patients: systematic review and meta-analysis by etiology. J Infect Dis 2012, 206(8):1250-1259.
25. French N., Gordon S.B., Mwalukomo T., White S.A., Mwafulirwa G., Longwe H., et al. A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults. N Engl J Med 2010, 362(9):812-822.
26. Bridges C.B., Woods L., Coyne-Beasley T. Advisory Committee on Immunization Practices (ACIP) recommended immunization schedule for adults aged 19 years and older-United States, 2013. Morb Mortal Wkly Rep Surveill Summ Wash DC 2002 2013, 62(févr (Suppl (1))):9-19. ACIP Adult Immunization Work Group. Centers for Disease Control and Prevention (CDC).
27. Centers for Disease Control and Prevention (CDC) Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2012, 61(Oct (40)):816-819.
28. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices. Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23). MMWR Morb Mortal Wkly Rep 2010, 59(Sept. (34)):1102-1106.
29. Goëb V., Ardizzone M., Arnaud L., Avouac J., Baillet A., Belot A., et al. Recommendations for using TNFα antagonists and French Clinical Practice Guidelines endorsed by the French National Authority for Health. Joint Bone Spine 2013, 80(6):574-581.
30. Annunziata K., Rak A., Del Buono H., DiBonaventura M., Krishnarajah G. Vaccination rates among the general adult population and high-risk groups in the United States. PLoS ONE 2012, 7(11):e50553.
31. Naleway A.L., Henkle E.M., Ball S., Bozeman S., Gaglani M.J., Kennedy E.D., et al. Barriers and facilitators to influenza vaccination and vaccine coverage in a cohort of health care personnel. Am J Infect Control 2014, 42(4):371-375.
32. Bonaccorsi G., Lorini C., Santomauro F., Guarducci S., Pellegrino E., Puggelli F., et al. Predictive factors associated with the acceptance of pandemic and seasonal influenza vaccination in health care workers and students in Tuscany, Central Italy. Hum Vaccines Immunother 2013, 9(12):2603-2612.
33. Doe S., Pathare S., Kelly C.A., Heycock C.R., Binding J., Hamilton J. Uptake of influenza vaccination in patients on immunosuppressant agents for rheumatological diseases: a follow-up audit of the influence of secondary care. Rheumatology 2006, 46(4):715-716.
34. Lanternier F., Henegar C., Mouthon L., Blanche P., Christophorov B., Cohen P., et al. Factors influencing influenza-vaccination in adults under immunosuppressive therapy for a systemic inflammatory disease. Méd Mal Infect 2009, 39(4):247-251.
35. Loulergue P., Mir O., Alexandre J., Ropert S., Goldwasser F., Launay O. Low influenza vaccination rate among patients receiving chemotherapy for cancer. Ann Oncol 2008, 19(9):1658.
36. Pradeep J., Watts R., Clunie G. Audit on the uptake of influenza and pneumococcal vaccination in patients with rheumatoid arthritis. Ann Rheum Dis 2007, 66(6):837-838.
37. Haroon M., Adeeb F., Eltahir A., Harney S. The uptake of influenza and pneumococcal vaccination among immunocompromised patients attending rheumatology outpatient clinics. Joint Bone Spine 2011, 78(4):374-377.
38. Sowden E., Mitchell W.S. An audit of influenza and pneumococcal vaccination in rheumatology outpatients. BMC Musculoskelet Disord 2007, 8:58.
39. Fahy W.A., Farnworth E., Yeldrem K.P., Melling G.S., Grennan D.M. Pneumococcal and influenza vaccination in patients with rheumatic conditions and receiving DMARD therapy. Rheumatology 2006, 45(7):912-913.
40. Pebody R.G., Hippisley-Cox J., Harcourt S., Pringle M., Painter M., Smith G. Uptake of pneumococcal polysaccharide vaccine in at-risk populations in England and Wales 1999-2005. Epidemiol Infect 2008, 136(3):360-369.
41. Ledwich L.J., Harrington T.M., Ayoub W.T., Sartorius J.A., Newman E.D. Improved influenza and pneumococcal vaccination in rheumatology patients taking immunosuppressants using an electronic health record best practice alert. Arthritis Care Res 2009, 61(11):1505-1510.
42. Feuchtenberger M., Kleinert S., Schwab S., Roll P., Scharbatke E.C., Ostermeier E., et al. Vaccination survey in patients with rheumatoid arthritis: a cross-sectional study. Rheumatol Int 2012, 32(6):1533-1539.
43. Mouthon L., Mestre C., Bérezné A., Poiraudeau S., Marchand C., Guilpain P., et al. Low influenza vaccination rate among patients with systemic sclerosis. Rheumatol Oxf Engl 2010, 49(3):600-606.
44. Actualisation de la liste des sujets éligibles à la vaccination contre la grippe saisonnière [Internet]. [cité 30 janv 2015]. Disponible sur: 〈http://www.hcsp.fr/Explore.cgi/avisrapportsdomaine?clefr=179〉.
45. van Assen S., Agmon-Levin N., Elkayam O., Cervera R., Doran M.F., Dougados M., et al. EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 2011, 70(3):414-422.
46. Nichol K.L., Mac Donald R., Hauge M. Factors associated with influenza and pneumococcal vaccination behavior among high-risk adults. J Gen Intern Med 1996, 11(11):673-677.
47. Nichol K.L., Lofgren R.P., Gapinski J. Influenza vaccination. Knowledge, attitudes, and behavior among high-risk outpatients. Arch Intern Med 1992, 152(1):106-110.
48. Jiménez-García R., Hernandez-Barrera V., Rodríguez-Rieiro C., Carrasco Garrido P., López de Andres A., Jimenez-Trujillo I., et al. Comparison of self-report influenza vaccination coverage with data from a population based computerized vaccination registry and factors associated with discordance. Vaccine 2014, 32(35):4386-4392.